Medy Tox Inc
KOSDAQ:086900
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
114 200
181 600
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Wall Street
Price Targets
Price Targets Summary
Medy Tox Inc
According to Wall Street analysts, the average 1-year price target for Medy Tox Inc is 135 320 KRW with a low forecast of 111 100 KRW and a high forecast of 155 400 KRW.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Medy Tox Inc's stock price target?
Price Target
135 320
KRW
According to Wall Street analysts, the average 1-year price target for Medy Tox Inc is 135 320 KRW with a low forecast of 111 100 KRW and a high forecast of 155 400 KRW.
What is Medy Tox Inc's Revenue forecast?
Projected CAGR
12%
For the last 11 years the compound annual growth rate for Medy Tox Inc's revenue is 17%. The projected CAGR for the next 3 years is 12%.
What is Medy Tox Inc's Operating Income forecast?
Projected CAGR
53%
For the last 11 years the compound annual growth rate for Medy Tox Inc's operating income is 2%. The projected CAGR for the next 3 years is 53%.
What is Medy Tox Inc's Net Income forecast?
Projected CAGR
57%
For the last 11 years the compound annual growth rate for Medy Tox Inc's net income is 1%. The projected CAGR for the next 3 years is 57%.
